| Authors: |
Svanberg Teglgaard R; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Marquart HV; Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark., Hartling HJ; Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark., Bay JT; Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark., da Cunha-Bang C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Brieghel C; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Faitová T; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Enggaard L; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Kater AP; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Lymphoma and Myeloma Center Amsterdam, Amsterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Kersting S; Department of Hematology, Haga Ziekenhuis, Den Haag, the Netherlands., Ostrowski SR; Department of Clinical Immunology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. |